Biosenic (CHIX:BIOSB) Research & Development: €2.31 Mil (TTM As of Dec. 2024)


CHIX:BIOSB Biosenic CHIX:BIOSB
9 GF Score
Price €2.60
View Full Analysis

What is Biosenic Research & Development?

Biosenic CHIX:BIOSB 9 Research & Development is €2.31 Mil as of Dec. 2024. GuruFocus rates CHIX:BIOSB with a GF Score™ of 9/100.

Research & Development is the aggregate amount of research and development expenses during the year. Biosenic's Research & Development for the six months ended in Dec. 2024 was €0.68 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €2.31 Mil.

Biosenic  (CHIX:BIOSb) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Biosenic Research & Development Related Terms

Biosenic Research & Development Historical Data

* Premium members only.

The historical data trend for Biosenic's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosenic Research & Development Chart

Biosenic Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.42 0.62 1.03 3.93 2.31

Biosenic Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 2.45 1.48 1.63 0.68
CHIX:BIOSB
9GF Score
Biosenic CHIX:BIOSB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosenic Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €2.31 Mil mean?
Biosenic (CHIX:BIOSB) has a Research & Development of €2.31 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Biosenic and its competitors.
Is Biosenic's Research & Development too high?
Biosenic's current Research & Development is €2.31 Mil. Overall, Biosenic has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Biosenic's Research & Development compare to VRTX and REGN?
Biosenic's Research & Development of €2.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Biosenic and its competitors. Biosenic's current Research & Development is €2.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosenic stock overvalued right now?
Biosenic (CHIX:BIOSB) has a current Research & Development of €2.31 Mil. The current Research & Development is €2.31 Mil. Biosenic's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Biosenic (CHIX:BIOSB), the current Research & Development is €2.31 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosenic Business Description

Address Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
9GF Score

Get the complete analysis for CHIX:BIOSB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.60
Price